
Molecular ‘cookie cutter’ method could provide key for COVID drug discovery
Researchers from the University of Birmingham are working to isolate and extract the COVID-19 encounter complex in a form that is stable enough for identification of target sites for future anti-viral drugs. The encounter complex is formed when the COVID-19 spike latches onto a binding site on an ACE-2 receptor,… Read More















